Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy.

European journal of cancer (Oxford, England : 1990) - 1 Apr 2021

Pacaud Alizé, Amintas Samuel, Boussemart Lise, Cappellen David, Gérard Emilie

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azetidines
Share to Gene Fusion
Share to Immune Checkpoint Inhibitors
Share to Mitogen-Activated Protein Kinase Kinases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Piperidines

Share to Proto-Oncogene Proteins c-raf

Share to Pyridones

Share to Pyrimidinones

Source

Identifiers

PMID: 33684875
DOI: 10.1016/j.ejca.2021.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy.PMID 33684875Read ↗

Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene.Semantic proximity Read ↗

Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profilesSemantic proximity Read ↗

B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant MelanomaSemantic proximity Read ↗

B-RAF: A contributor to the melanoma phenotype.Semantic proximity Read ↗

Narrative review: BRAF opens the door for therapeutic advances in melanoma.Semantic proximity Read ↗

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.Semantic proximity Read ↗

Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma.Semantic proximity Read ↗

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review.Semantic proximity Read ↗

A Progressive Review of V600E-B-RAF-Dependent Melanoma and Drugs Inhibiting It.Semantic proximity Read ↗

Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedside.Semantic proximity Read ↗

Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?Semantic proximity Read ↗

Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic OverviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.